Closed Protocol
Resources for Members
Clinical Trials
Files with the extension 'zip' require the Winzip application to open.
2007-387
E1505: A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) more details
Protocol
Consent Form
|
|
| |
2008-061
A PHASE 1/2 STUDY OF XL184 WITH OR WITHOUT ERLOTINIB IN SUBJECTS WITH NON-SMALL CELL LUNG CANCER more details
Protocol
Consent Form
|
|
| |
2008-137
A Phase I Followed by a Randomized, Phase II Study of Carboplatin and Etoposide
with or without Obatoclax Administered Every 3 Weeks to Patients with Extensive-Stage
Small Cell Lung Cancer (ES-SCLC) more details
Protocol
Consent Form
|
|
| |
2008-062
A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the
Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as Adjuvant
Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer more details
Protocol
Consent Form
|
|
| |
2008-602
Randomized,Phase III,Double-Blind Placebo-Controlled Trial of Sunitinib as Maintaenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer more details
Protocol
Consent Form
|
|
| |
2008-433
A Phase Ib/2a Open-Label Study to Evaluate the Safety and Activity of Once Daily Oral Administration of AV-951 in Subjects with Non-Small Cell Lung Cancer more details
Protocol
Consent Form
|
|
| |
2008-605
A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of ASA4004 in Combination with Docetaxel as Second-Line Treatment for Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer more details
Protocol
Consent Form
|
|
| |
2009-088
Phase 2 Randomized Study of Carboplatin/Paclitaxel with or without CS-7017 in Chemotherapy Naive Subjects with Metastatic Non-Small Cell Lung Cancer more details
Protocol
Consent Form
|
|
| |
2008-305
CALGB 30704: a Randomized Study to Assess the Efficacy of Pemetrexed or Sunitinib (NSC #736511, IND #74019) or Pemetrexed plus Sunitib in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer more details
Protocol
Consent Form
|
|
| |
|